Literature DB >> 10442146

Viral markers in a blood donor population.

J W Mwangi1.   

Abstract

BACKGROUND: The viral safety of blood depends on donor selection and screening of the blood for viruses.
OBJECTIVE: To determine the frequency of human immunodeficiency viruses 1 and 2, hepatitis B virus and hepatitis C virus in a population of donors.
DESIGN: Retrospective study including all blood donations at a hospital-based transfusion unit between January 1995 and August 1998.
RESULTS: A significant declining trend in the frequency of the human immunodeficiency virus from 4.5% in 1995 to 3.0% in 1998 was noted. Hepatitis B virus (HBV) decreased from 4.2% in 1995 to 3.9% in 1998, while hepatitis C (HCV) increased from 1.5% in 1996 to 1.8% in 1998. The changes for both HBV and HCV were not statistically significant.
CONCLUSION: The safety of blood and blood products with respect to HIV, HBV and HCV is very high. It is important to educate donors regarding transfusion transmitted infections. It is recommended that HCV screening be implemented as a standard test for all donations.

Entities:  

Mesh:

Year:  1999        PMID: 10442146

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  3 in total

1.  Visual detection of multiple viral amplicons by dipstick assay: its application in screening of blood donors a welcome tool for the limited resource settings.

Authors:  B R Panhotra; Z U Hassan; C S Joshi; A Bahrani
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

2.  The Burden of Hepatitis B, Hepatitis C, and Human Immunodeficiency Viruses in Ovarian Cancer Patients in Nairobi, Kenya.

Authors:  Francis Mugeni Wanyama; Rudolf Tauber; Alfred Mokomba; Catherine Nyongesa; Véronique Blanchard
Journal:  Infect Dis Rep       Date:  2022-06-07

3.  Giving tranexamic acid to reduce surgical bleeding in sub-Saharan Africa: an economic evaluation.

Authors:  Carla Guerriero; John Cairns; Sudha Jayaraman; Ian Roberts; Pablo Perel; Haleema Shakur
Journal:  Cost Eff Resour Alloc       Date:  2010-02-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.